Back to Search
Start Over
Patritumab Deruxtecan in Untreated Hormone Receptor–Positive/HER2-Negative Early Breast Cancer: Final Results from Part A of the Window-of-Opportunity SOLTI TOT-HER3 Pre-Operative Study
- Source :
- Annals of Oncology.
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
- Subjects :
- Oncology
Hematology
Subjects
Details
- ISSN :
- 09237534
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........45cedf218aa6e303442743c2ee952cca
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.05.004